Henan Taloph Pharmaceutical Stock Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000010L8
CNY
8.58
0.54 (6.72%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
435.48
321.70
597.03
411.53
425.30
496.43
623.42
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
435.48
321.70
597.03
411.53
425.30
496.43
623.42
Raw Material Cost
345.33
244.36
467.87
328.26
309.92
368.95
434.66
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
10.40
14.35
15.62
13.50
13.50
13.71
13.48
Selling and Distribution Expenses
59.71
50.26
76.89
65.53
66.00
74.22
97.41
Other Expenses
0.01
-0.34
0.59
0.13
2.01
0.83
0.94
Total Expenditure (Excl Depreciation)
415.57
305.59
566.32
408.54
409.48
465.14
554.99
Operating Profit (PBDIT) excl Other Income
19.9
16.1
30.7
3
15.8
31.299999999999997
68.4
Other Income
1.92
1.17
4.49
1.93
1.59
1.83
11.86
Operating Profit (PBDIT)
50.80
35.67
40.93
28.42
39.09
48.10
101.11
Interest
10.40
14.35
15.62
13.50
13.50
13.71
13.48
Exceptional Items
1.31
0.14
1.82
5.62
0.75
-0.24
-1.13
Gross Profit (PBDT)
90.15
77.35
129.16
83.27
115.38
127.48
188.76
Depreciation
18.77
18.77
17.58
17.58
19.02
19.02
18.50
Profit Before Tax
22.93
2.69
9.55
2.95
7.31
15.13
68.01
Tax
1.74
0.01
-12.89
-1.26
-0.64
-3.63
-0.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
17.82
1.53
21.63
2.28
5.36
21.26
60.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
17.82
1.53
21.63
2.28
5.36
21.26
60.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.15
1.10
1.92
1.64
0.15
-0.74
3.87
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
19.97
2.63
23.55
3.92
5.51
20.52
64.35
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,600.36
1,578.41
1,574.73
1,570.34
1,552.01
1,586.11
1,578.49
Earnings per share (EPS)
0.03
0.0
0.04
0.0
0.01
0.04
0.11
Diluted Earnings per share
0.03
0.0
0.04
0.0
0.01
0.04
0.11
Operating Profit Margin (Excl OI)
6.91%
4.89%
3.16%
2.16%
4.35%
5.49%
11.35%
Gross Profit Margin
9.58%
6.67%
4.54%
4.99%
6.19%
6.88%
13.88%
PAT Margin
4.09%
0.48%
3.62%
0.55%
1.26%
4.28%
9.7%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2025 is 2.40% vs -1.44% in Jun 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2025 is 263.64% vs 111.93% in Jun 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2025 is 30.40% vs 282.93% in Jun 2024

stock-summary

Interest

YoY Growth in quarter ended Jun 2025 is -22.96% vs 8.00% in Jun 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024

Compare Quarterly Results Of Henan Taloph Pharmaceutical Stock Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
435.48
0
435.48
Other Operating Income
0.00
0.00
0.00
Total Operating income
435.48
0
435.48
Raw Material Cost
345.33
0
345.33
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
10.40
0
10.40
Selling and Distribution Expenses
59.71
0
59.71
Other Expenses
0.01
0.00
0.01
Total Expenditure (Excl Depreciation)
415.57
0
415.57
Operating Profit (PBDIT) excl Other Income
19.91
0.00
19.91
Other Income
1.92
0
1.92
Operating Profit (PBDIT)
50.80
0
50.80
Interest
10.40
0
10.40
Exceptional Items
1.31
0
1.31
Gross Profit (PBDT)
90.15
0
90.15
Depreciation
18.77
0
18.77
Profit Before Tax
22.93
0
22.93
Tax
1.74
0
1.74
Provisions and contingencies
0
0
0.00
Profit After Tax
17.82
0
17.82
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
17.82
0
17.82
Share in Profit of Associates
0
0
0.00
Minority Interest
2.15
0
2.15
Other related items
0.00
0.00
0.00
Consolidated Net Profit
19.97
0
19.97
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,600.36
0
1,600.36
Earnings per share (EPS)
0.03
0
0.03
Diluted Earnings per share
0.03
0
0.03
Operating Profit Margin (Excl OI)
6.91%
0%
0.00
6.91%
Gross Profit Margin
9.58%
0%
0.00
9.58%
PAT Margin
4.09%
0%
0.00
4.09%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 43.55 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 35.37% vs -46.11% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 2.40% vs -1.44% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.00 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 669.23% vs -88.94% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 263.64% vs 111.93% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.89 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 41.74% vs -5.22% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 30.40% vs 282.93% in Jun 2024

Quarterly - Interest
Interest 1.04 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -27.78% vs -7.69% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -22.96% vs 8.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.91%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024